Purchase Order W91ZLK22P0086

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order contract to Genscript USA Inc., a for-profit biotechnology company, for stable cell line development services with a completion date of April 1, 2020. The contract had a potential value of $130,400.99 and was not set aside for any particular business type. Genscript provides a range of molecular biology products and services, including gene synthesis, gene editing,...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $231,000.00 firm-fixed-price purchase order to Life Technologies Corporation, a for-profit manufacturer, for the provision of EXPI293F license and cell lines. This contract does not have a set-aside designation. The products and services are to be delivered by the July 31, 2021 completion date. Life Technologies Corporation is a subsidiary of the parent company Thermo Electron Corporation, which...

This federal contract award from the National Institute of Child Health and Human Development (NICHD), a component of the U.S. Department of Health and Human Services, is for a Firm Fixed Price Purchase Order with Genscript USA Inc. to provide "STABLE RESEARCH CELL LINE SERVICE, INCLUDES SHIPPING CHARGES". The contract has a ceiling value of $9,885.25 and an ultimate completion date of February 28, 2011. Genscript USA Inc. is a biotechnology company that specializes in supplying...

This is a firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $21,277.24, is for the generation of a POLH/POLI knockout MRC5SV cell line and other associated services. The contract does not have a set-aside designation. Genscript is a well-established...

Codex Biosolutions Inc. has been awarded a firm fixed price purchase order valued at $22,620 by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health within the Department of Health and Human Services, to deliver an EXPI293 stable cell line overexpressing HTLV envelope protein in support of NIAID's efforts to develop treatments and preventions for infectious diseases. The research and development will be conducted by Codex...

The National Institutes of Health awarded a $249,942 firm fixed price purchase order to Wicell Research Institute, Inc. to obtain 128 specific human pluripotent stem cell lines in support of the Helping to End Addiction Long-term Initiative. The award was made non-competitively based on Wicell being the only source capable of providing the cell lines due to scientific continuity needs. Prior to shipment, each cell line must undergo testing to verify identity, sterility, and normal karyotype....

This is a firm fixed-price call order awarded to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey, by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services. The $14,190.07 contract is for the provision of services related to host cell line and strain preparation (contract number 75N98024A00139|75N94024F00001). The contract has a period of performance ending on July 31, 2025 and...

This federal contract award to Lonza Walkersville, Inc. Walkersville Division, a subsidiary of the global company Lonza Group Ltd., is for the supply of Biopredic International NoSpin HepaRG cells to the Food and Drug Administration (FDA). The $40,666.00 firm-fixed-price purchase order is to support research at the National Center for Toxicological Research (NCTR) on the cytotoxicity and genotoxicity of small-molecule nitrosamines and nitrosamine drug substance-related impurities. The key...

This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The $99,560.52 firm-fixed-price purchase order is for the delivery of various media and supplements for the CompacT SelecT automated cell culture system used by the NIH's Stem Cell Translation Laboratory to support research on opioid...

The Environmental Protection Agency Office of Research and Development awarded a $15,680 firm fixed price purchase order to Creative Biolabs Inc. of East Yaphank, New York. The contract is for the generation of a custom T cell receptor (TCR)-Jurkat cell pool, with work to be completed by October 16, 2024 and no set-aside designation used. As part of its efforts to safeguard human health and the environment, the EPA conducts research on technologies like cell receptors that could help detect...